NaCl solution Placebo

BIOLOGICAL2 trials

Sponsors

MAXVAX Biotechnology Limited Liability Company

Conditions

Herpes Zoster

Phase 3

Efficacy, Safety and Immunogenicity Study of Recombinant Zoster Vaccine(CHO Cell) in Adults Aged 40 Years and Older

Active, not recruitingNCT06447779

MAXVAX Biotechnology Limited Liability CompanyHerpes Zoster

Start: 2024-07-13End: 2027-09-30Target: 25000Updated: 2024-10-24

A Phase III Clinical Trial to Evaluate Long-Term Protective Efficacy of Recombinant Zoster Vaccine (CHO Cell)

Active, not recruitingNCT07293065

MAXVAX Biotechnology Limited Liability CompanyHerpes Zoster

Start: 2025-12-15End: 2028-12-31Target: 12000Updated: 2026-03-10